Recent Ozempic, Victoza data ‘promising’ for diabetic kidney disease

25th June 2019 Uncategorised 0

Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk talks exclusively to PharmaTimes.

More: Recent Ozempic, Victoza data ‘promising’ for diabetic kidney disease
Source: News